Laura Joszt, MA

The rising cost of drugs is a cause for concern among various stakeholders in healthcare, some of who worry that staying on the current trajectory will “break the bank,” said panelists during a session at the ISPOR Annual Meeting.

At the Pharmacy Quality Alliance's Annual Meeting, Kate Goodrich, MD, of CMS, and a group of experts discussed the government's move toward value-based care and the use of quality measures.

HHS and the Department of Justice announced a nationwide sweep led by the Medicare Fraud Strike Force resulting in charges against 301 individuals for their alleged participation in healthcare fraud schemes involving $900 million in false billings.

The Department of Justice has found that the Nevada Department of Corrections has been discriminating against inmates with HIV and with disabilities, according to a letter of findings issued.

Addressing the unmet social needs of patients requires additional investment on the part of the healthcare industry, but provides a tangible return on investment.

Coverage from the 2016 Spring Live Meeting of the ACO & Emerging Healthcare Delivery Coalition on April 28-29, 2016, in Scottsdale, Arizona.

The Supreme Court ruled to uphold a new process for challenging patents that the pharmaceutical industry was hoping would be struck down. Generic drug companies and health insurance plans supported the new rule, which could help lower prices.

The healthcare ecosystem can be a very complex place, and it’s important to remember that a patient sits at the center, explained David M. Cordani, president and CEO of Cigna Corp., during a general session on the second day of America’s Health Insurance Plans’ Institute & Expo.

As America’s Health Insurance Plans’ Institute & Expo kicked off in Las Vegas on June 15, Susan Dentzer, president and CEO of The Network for Excellence in Health Innovation, moderated a panel discussion on the possibility of delivery better healthcare at a lower cost.

Healthcare leaders and experts will come together to discuss disruptors, consumer engagement, digital health, and more at the AHIP Institute & Expo, being held June 15-17 in Las Vegas.

A new analysis from The Commonwealth Fund has found that the Cadillac tax will likely be more progressive than initially thought.

States are taking the lead in the fight against rising drug prices. Vermont has passed legislation to regulate yearly drug price hikes and other states have introduced similar legislation.

New hepatitis C virus treatments may be extraordinarily effective, curing the disease in many cases, but the high cost has posed an enormous economic challenge that speakers outlined during a briefing in Washington, DC.

Access to care remains an issue for many US veterans, but a new initiative between the Department of Veterans Affairs Palo Alto Health Care System and MinuteClinic could expand access to care in Northern California.

One year after being hospitalized for heart failure, one-third of patients had not returned to work, according to a study presented at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure.

Value, cost, and the patient are taking center stage during the ISPOR 21st Annual International Meeting, which is being held May 21-25, 2016, in Washington, DC.

Researchers set out to analyze the clinical outcomes in a real-world clinical setting of patients with T2D who switched to Toujeo from another basal insulin.

Survival rates increase as more quality measures are incorporated into care, but only 13% of eligible patients with Stage IIIA non-small cell lung cancer actually receive all 4 measures.

Over the last year, The American Journal of Managed Care has covered many aspects of the hepatitis C issue: access to treatment, the cost of drugs, exclusivity deals, and more. Here are the most-read articles from the last year.

At the spring live meeting of the ACO & Emerging Healthcare Delivery Coalition in Scottsdale, Arizona, attendees heard presentations and participated in workshops that discussed better integration of care, improved use of technology, and the future of healthcare and the Affordable Care Act.

Two doctors have been found guilty of falsely certifying Medicare patients were terminally ill and qualified for hospice care. However, the vast majority of the patients actually were not dying.

Accountable care organizations can improve outcomes and patient experience while reducing costs through integrated care and better use of technology.

Cost, biosimilars, and technology dominated the conversations when managed care pharmacists, health plan administrators, physicians, and more gathered for the AMCP Managed Care & Specialty Pharmacy Annual Meeting in San Francisco, April 19-22, 2016.

The current reactive healthcare system is driving digital health innovations, Yoona Kim, PharmD, PhD, head of clinical modeling and analytics with Proteus Digital Health, said at the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2016.

The drug abuse epidemic in the US has placed attention on opioids and panelists during a session at the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2016 discussed the current state of treatment for opioid addiction and future changes that may be on the way.

As healthcare moves to value-based arrangements and delivery models like accountable care organizations (ACOs), the benefit of incorporating a pharmacist can be overlooked. Tina Joseph, PharmD, BCACP, and Reena Jones, PharmD, CPh, both from Nova Southeastern University, outlined how pharmacists can be integrated into ACOs in order to improve care and patient satisfaction, while reducing cost.

AMCP Managed Care & Specialty Pharmacy Annual Meeting 2016 kicked off by delving into the near-term specialty pharmaceutical pipeline with Aimee Tharaldson, PharmD, senior clinical consultant of emerging therapies at Express Scripts.

With patients increasingly demanding more of anyone involved in their healthcare, technology is playing an important role, explained panelists at a session of Specialty Pharmacy Connect, a pre-meeting program held ahead of the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2016.

The specialty pharmacy industry is unique in many ways, but the price growth for these drugs is no longer sustainable, Steve Miller, MD, senior vice president and chief medical officer of Express Scripts, said during a pre-meeting session of AMCP Managed Care & Specialty Pharmacy Annual Meeting 2016.

UnitedHealth Group started the year in 34 insurance exchanges, but that number will be a lot less come 2017. CEO Stephen Hemsley announced that the company will only participate in a "handful" of Affordable Care Act exchanges next year.